A baculovirus expression vector (AcLeon) derived from Autographa californica nuclear polyhedrosis virus (AcNPV) was prepared containing the complete 6.6 kb coding region of the P3/Leon/37 strain of poliovirus type 3 placed under the control of the AcNPV polyhedrin promoter. The recombinant virus was used to infect Spodoptera frugiperda insect cells. As demonstrated by use of the appropriate antibodies, infected insect cells made poliovirus proteins that included the structural proteins VP0, VP1 and VP3. Poliovirus particles were recovered from extracts of the infected cells and demonstrated to be free from detectable levels of RNA and to be non-infectious in tissue culture. After particle purification by CsC1 gradient centrifugation and immunization of outbred mice, antibodies to the structural proteins, including neutralizing antibodies, were obtained. Other recombinant baculoviruses, containing the majority of the capsid coding region of P3/Leon/37 (e.g. AcCAP21, nucleotide residues 742 to 3318), made an unprocessed precursor to the poliovirus structural proteins. These data suggested that processing of the poliovirus gene product by the AcLeon construct was catalysed by the poliovirus-encoded proteases. The results demonstrated that antigenic and immunogenic poliovirus proteins and empty particles can be made in insect cells by recombinant baculoviruses.
INTRODUCTION
The genome of polioviruses, like that of other picornaviruses, is composed of a single strand of positive-sense RNA (approx. 7450 nucleotides long; Kitamura et al., 1981; Racaniello & Baltimore, 1981 ; Stanway et al., 1983 Stanway et al., , 1984 Toyoda et al., 1984) . The viral RNA is encapsidated in a virus particle by the structural proteins VP1, VP2, VP3 and VP4. Upon entry to a permissive cell, the RNA is translated into a polyprotein. Translation of the viral polyprotein is not initiated at the first, Y-proximal AUG, but begins at a later AUG (nucleotide residues 743 to 745 for the P3/Leon/37 strain of poliovirus type 3). During translation, the viral polyprotein is processed via a variety of intermediates into the various poliovirus proteins through the action of at least two virus-coded proteases (Hanecak et al., 1982; Toyoda et al., 1986) . When infectious virus is produced in permissive cells, the structural proteins include the capsid proteins, VP1 to VP4. An intermediate precursor to two of these proteins, VP2 and VP4, is the VP0 polypeptide (Holland & Kiehn, 1968; Jacobson & Baltimore, 1968; Jacobson et aL, 1970) . Cleavage of VP0 is apparently a late event in the processing and morphogenetic pathway of poliovirus and is believed to be catalysed by the encapsidated poliovirus RNA.
The three-dimensional (3D) crystallographic structure of poliovirus type 1 has been determined (Hogle et al., 1985) . By using a variety of neutralizing monoclonal antibodies and analyses of neutralization-resistant mutants, the antigenic domains on poliovirus types 1 and 3 have been characterized and assigned to the 3D structure of the virus (Blondel et al., 1986; Diamond el al., 1985; Hogle et al., 1985; Minor et al., 1983 Minor et al., , 1985 Minor et al., , 1986 van der Weft et al., 1983) . By genetic engineering procedures chimeric poliovirus particles have been made that are infectious and immunogenic, raising the possibility that new types of vaccines may be produced by such procedures (Burke et at., 1988) .
In order to explore the question of whether non-infectious poliovirus particles, including novel constructs, could be made from eukaryotic expression vectors, the complete coding region (nucleotide residues 743 to 7363) of the P3/Leon/37 strain of poliovirus type 3 has been inserted into a baculovirus transfer vector, pAcYM 1 (Matsuura et al., 1987) . A recombinant baculovirus, designated AcLeon, was derived from Autographa californica nuclear polyhedrosis virus (AcNPV), and used to infect Spodoptera frugiperda insect cells. The synthesis of poliovirus structural proteins and non-infectious poliovirus particles by this baculovirus is described. Other recombinant baculoviruses, e.g. AcCAP21, have been prepared containing only the capsid coding region of the poliovirus. Such recombinants make an unprocessed polypeptide representing the majority of the structural protein sequences.
METHODS

Viruses and cells.
Wild-type AcNPV and the recombinant baculoviruses were grown and plaque-assayed in S. frugiperda cells (Brown & Faulkner, 1977) . The P3/Leon/37 strain of poliovirus type 3 was grown and assayed in HEp-2c, Veto or GMK cells as described previously (Minor, 1980) . DNA manipulations. Plasmid DNA manipulations were carried out essentially as described by Maniatis et al. (1982) . Restriction enzymes, T4 ligase and the Ktenow large fragment of DNA polymerase were purchased from Amersham and calf intestinal alkaline phosphatase came from Boehringer Mannheim.
Construction of DNA clones, pOLIO LEON (Stanway et al., 1984) was digested to completion with BgllI and partially digested with BamHI. The resulting 2.75 kbp fragment contained 69 bp of the 5' non-coding region, the ATG translation start signal, all of the P1 capsid protein region and 45 bp of the P2 non-structural protein region. This fragment was ligated into a BamHI-digested, phosphatase-treated, expression vector (pl2RHCMV) containing the long terminal repeat (LTR) of Rous sarcoma virus (RSV) and the termination signals from the major immediate early gene of human cytomegalovirus. The resulting plasmid was designated p 12RCAP. In order to remove the P2 region completely, an NdeI-BamHI linker was constructed which contained the viral coding sequence encompassing the NdeI site (viral residue 3374) through the end of the P1 capsid region (residue 3376), a new in-frame stop codon and a unique Xhol site. The sticky-ended linker and an NdeI-PstI fragment from pl 2RCAP (residues 2609 to 3374) were ligated into the products ofa PstI and BamHI digest ofpl2RHCMV. The resulting plasmid, pl2RCAPF0, was then digested with PstI, treated with alkaline phosphatase and ligated to the 1.9 kbp PstI fragment recovered from pl2RCAP to give pRSVCAP-Lo. This plasmid, representing poliovirus P3/Leon/37 residues 673 to 3376, therefore contained 69 bases from the 5' non-coding region and the whole of the capsid region of the virus (nucleotide residues 743 to 3376) followed by an in-frame stop codon. None of the P2 region sequence was present. The pRSVCAP-Lo plasmid was digested with the restriction enzymes SalI and XhoI and the products treated with Bal 31 to remove the majority of the residual 5' non-coding nucleotides (Fig. 1) . After ligation into the dephosphorylated HincII site of plasmid pUC 19 the recombinant plasmids were sequenced at the plasmid insertion sites. One was initially selected that contained poliovirus residues 742 to 3318 (pA79 shown in Fig. 1 , lacking 20 amino acids from the carboxy-terminus of the VP1 coding sequences). The plasmid was treated with the enzymes XbaI and HindIII and the products were filled in with the Klenow large fragment of DNA polymerase. A 2-6 kbp fragment containing the poliovirus sequence was recovered and ligated into the BamHIcut, filled-in, dephosphorylated site of the 9.3 kbp transfer vector pAcYM1 (Matsuura et al., 1987) . The recombinant transfer vector pAcCAP21 was recovered and the orientation of the poliovirus sequence verified by sequence analyses (Fig. 1) . A second plasmid from the Bal 31 digestion was also recovered and used to prepare a transfer vector. This vector was designated pAcCAP69. It contained the poliovirus sequence starting at residue 736 and ending at residue 3318.
In addition to preparing recombinant baculoviruses that synthesized a precursor to the poliovirus structural proteins (see below), the pAcCAP21 vector was employed to make a second transfer vector containing the entire coding region of the poliovirus genome. Plasmid pRSV-APBCAT M z, containing the BamHI-SstI fragment of pOLIO LEON (residues 674 to 752) and the chloramphenicol acetyltransferase (CAT) gene under the control of the RSV LTR [and with the SV40 small t intron, poly(A) and transcription termination signals], was digested with SstI and SalI to remove the CAT gene and ligated to the 5.5 kbp SstI-SalI fragment (residues 1900 to 7431) of fulllength P3/Leon/37 DNA restricted at the extreme 3' end with SaII. This gave a plasmid designated pRSV-Leon- 1455 APB-AS. The plasmid was then digested with SstI and treated with alkaline phosphatase. Into the product, the 1148 bp SstI fragment from pOLIO LEON was inserted to produce plasmid pRSV-Leon-APB. The pRSV-Leon-APB plasmid thus contained the full poliovirus P3/Leon/37 nucleotide sequence except for the first 673 bases of the 5' non-coding region. Plasmid pRSV-Leon-APB was treated with PstI and a 4.9 kbp fragment, representing residues 2604 to 743 | of the viral genome, was cloned into the dephosphorylated PstI site of the bacterial plasmid pUC-4K (Fig. 1) . The derived recombinant plasmid, pUC4-Leon, was treated with BamHI and the poliovirus sequences were recovered and ligated into the BamHI-cut, dephosphorylated site of pAcYM1 tproducing the recombinant pAc4.9KLeon; see Fig. 1 ). The transfer vector pAcCAP21 was treated with the enzymes SmaI and SnaBl, the products were dephosphorylated and ligated to a 4-8 kbp DNA fragment derived by SmaI and SnaBI digestion of plasmid pAc4.9KLeon. By this means the recombinant transfer vector pAcLeon-YM 1 was recovered in which the entire coding region of the poliovirus (encompassing residues 743 to 743l of the poliovirus genome) was positioned under the control of the baculovirus polyhedrin promoter (see Fig. l ).
Cotransfection and selection of recombinant viruses. Recombinant viruses, AcCAP2I, AcCAP69 and AcLeon, were obtained from cotransfections involving wild-type AcNPV DNA and the individual transfer vector DNAs (pAcCAP21, pAcCAP69 and pAcLeon-YM1, respectively) as described by Matsuura et al. (1987) . Five independently isolated clones of virus from the pAcCAP21 transfections were obtained, AcCAP21-2G and AcCAP21-T3, -T4, -T5 and -T8. Two clones of virus from the pAcCAP69 transfections were obtained and designated AcCAP69-1-1 and AcCAP69-4-1.
Pulse-labelling with [3SS]methionine. S.frugiperda cells (106 cells per 35 mm dish) were infected with recombinant
baculoviruses at multiplicities of approx. 5 to 10 p.f.u./cell, grown at 28 °C and pulse-labelled with 30 ~tCi pS]methionine (Amersham, 8000 Ci/mmol) for 2 h at 36 h post-infection using methionine-free medium. Prior to labelling, the cells were incubated for 1 h in methionine-free medium in order to reduce the intracellular pools of free methionine. After the labelling periods, the cells were resuspended in 1 ml of phosphate-buffered saline (PBS), washed three times and finally resuspended in 100 ~1 of PBS. Portions were boiled for 5 min in protein dissociation buffer (2.3~ SDS, 10~ glycerol, 5~ 2-mercaptoethanol, 62-5 mM-Tris-HCl, 0.01 ~ bromophenol blue, pH 6.8) and resolved by SDS-PAGE.
Western blot analyses of proteins. S. frugiperda cells were infected with recombinant baculoviruses at multiplicities of 5 to 10 p.f.u./cell and incubated for 48 h at 28 °C. Mock-infected or virus-infected cells were washed twice with PBS and extracted for protein. Protein samples of cell extracts or purified virus particles were resolved by SDS-PAGE, after which each gel was treated for 30 min with buffer (25 mM-Tris-HC1, 192 mMglycine in 20~ methanol, pH 8-3). For Western blot analyses the proteins were transferred by electroblotting for 3 h at 0-8 mA/cm 2 using a Sartoblot II (Sartorius) and the semi-dry transfer procedure described by Kyhse-Andersen (1984) using an Immuobilon transfer membrane (Millipore), pretreated for 15 s with 100~ methanol and then treated for 10 min with the electroblotting buffer. The membrane was placed in a blocking solution consisting of 5~ skimmed milk and 0.05~ Tween-20 made up in PBS and left overnight at 4 °C. Individual or mixed rabbit polyclonal anti-VP l peptide (VP 1 amino acids 282 to 292, serum R238), anti-VP2 peptide (VP2 amino acids 160 to 173, serum R266) and anti-VP3 peptide (VP3 amino acids 53 to 68, serum R200) diluted 600-fold in blocking solution, was added for lb. On occasion a mouse ascitic polyclonal antibody raised to the expressed particles was employed. Membranes were washed with 0-05~ Tween 20 in PBS before reaction with goat anti-rabbit or antimouse immunoglobulins conjugated with alkaline phosphatase. After 1 h and multiple washings, the bound enzyme was assayed using fl-naphthyl phosphate (Sigma) according to the manufacturer's instructions.
Purification of expressed poliovirus particles. S.frugiperda cells were infected with the recombinant AcLeon virus
at a multiplicity of 5 to 10 p.f.u./cell and harvested at either 4 or 5 days post-infection. The cells were washed twice with PBS, resuspended in 10 mM-Tris-HC1 buffer pH 7.4, and sonicated until lysis occurred. After low speed centrifugation to remove cellular debris, the lysate was extracted twice with fluorocarbon (1,1,2-trichlorotrifluoroethane, Aldrich), the aqueous layer recovered and centrifuged at 40000 r.p.m, for 1 h. The pelleted material was resuspended in PBS and layered on a preformed, discontinuous CsC1 gradient made up in PBS (using layers of 3 ml, 4 ml and 4 ml of densities, 1-4, 1-3 and 1-2 g/ml respectively). The gradient was centrifuged at 40000 r.p.m, for 17 h in a Type 70.1 Beckman rotor. The visible band of virus particles was collected, diluted and either repurified by gradient centrifugation or pelleted and resuspended in 10 mM-Tris-HC1 buffer pH 7.4. Protein estimates were made using bovine serum albumin as a standard.
Electron microscopy. Purified virus particles were negatively stained with uranyl formate and observed in an electron microscope.
Production ofhyperimmune asciticfluids. Two P.O. mice were each inoculated by the iiatraperitoneal route with 50 ~tg of purified viral antigen in Freund's complete adjuvant on day 0, followed by two successive booster inoculations of 50 vtg antigen in Freund's incomplete adjuvant (on days 8 and 35). On day 28 both mice were inoculated by intraperitoneal injection with 1 x 106 Ehrlich ascites cells. Ascitic fluids were removed by paracentesis at intervals from day 41 to day 49. Neutralizing antibody assays employed HEp-2c cells in a TCIDs0 test using microtitre plates.
RESULTS
Construction of the recombinant baculoviruses
The objectives of the study were to express and characterize the poliovirus products made in insect cells by recombinant baculoviruses. To this end two types of recombinant baculoviruses were prepared. For one recombinant, AcLeon, the complete coding region of DNA representing poliovirus type 3 (P3/Leon/37) was inserted into the genome of AcNPV in lieu of the AcNPV polyhedrin protein coding region. As described in Methods and illustrated in Fig. 1 this involved the removal of the 5' non-coding region from a plasmid containing the poliovirus sequence in order to delete the poliovirus upstream ATGs and to limit the length of the 5' non-coding region of the baculovirus transcripts. The derived transfer vector pAcLeon-YM1 contained the entire promoter sequence of the polyhedrin gene that is required for high level expression, that is, up to the + 1 nucleotide (Matsuura et al., 1987) , followed by a sequence of 14 nucleotides derived from linkers used in the manipulations, then by the poliovirus sequence starting with the A (residue number 742, Fig. 2, i. e. equal to residue -1 relative to the ATG of the coding region). The 3' end sequences of the inserted DNA included the poly(A) and poly(C) tails as well as residues of the linkers used in the constructions (Fig. 2) . The transfer vector was used to prepare a recombinant virus designated AcLeon.
The other type of recombinant virus that was made contained the majority of the capsid region of the poliovirus (recombinants AcCAP21 and AcCAP69). They were prepared as described in Methods. Due to the plasmids and procedures used to construct the viruses, the AcCAP21 recombinants contained the same 5' configuration at the insertion site as the AcLeon virus. As illustrated in Fig. 2 , due to the Bal 31 digestion, the 3' sequence of the inserted gene in the transfer vector, which was used to prepare the AcCAP21 viruses, ended at residue 3318 and was followed by 27 extra nucleotides derived from the linkers used in the construction. This sequence codes for six extra amino acids before the stop codon (Fig. 2) . Whether the presence of these extra amino acids influenced the synthesis of the capsid proteins, or exerted other effects on the expression of the poliovirus gene products, is not known. In the case of the vector used to prepare the AcCAP69 viruses there were seven poliovirus nucleotides upstream of the translation initiation ATG (i.e. the poliovirus 5' inserted sequence was ...TGTCACAATGGG .... see Fig. 2 ). The poliovirus Y sequence in this vector was the same as that in pAcCAP21. In Fig. 3 is shown a photograph of gradient-purified virus particles recovered from recombinant AcLeon virus-infected S. frugiperda cells. The particles were observed as an opalescent band at a density determined to correspond to 1.30 g/ml. With antisera raised to poliovirus VP1, VP2 and VP3 peptide sequences, Western blot analyses demonstrated that the proteins extracted from the purified particles included the 33K poliovirus VP1 protein (Fig. 4,  lane 1) and the 26K VP3 protein (Fig. 4, lane 3) . No VP2 protein was demonstrated. However, a protein corresponding to the size of the poliovirus 38K VP0 protein reacted with the VP2 antisera (Fig. 4, lane 2) .
Characterization of the virions made in AcLeon virus-infected S. frugiperda cells
Poliovirus cDNA and AcNPV D N A probes were employed in Northern blot analyses using material extracted from purified virions. The probes did not detect any poliovirus, or AcNPV- From four separate experiments the quantity of particles recovered by gradient centrifugation was estimated by comparing the stained protein profiles (using Coomassie Brilliant Blue, see Fig. 6 ) to the level of staining obtained with known amounts of bovine serum albumin. It was calculated that from every litre of 2 x 10 9 infected cells, an average of 60 ~tg of virion protein was recovered. Considerable variation was obtained between experiments (20 to 180 ~tg/1), the reason for which is under investigation. Between experiments no comparison was made of how much virus was lost during the purification procedure. Assuming that there are 60 copies of the 97K capsid proteins (i.e. 5.8 x 106 total Mr of protein per particle) and 60 ~tg particles per litre of cell culture, then on the basis of Avogadro's formula (i.e. 2 x 1023 particles per gram molecular weight) this yield represents 2 × 1012 particles (i.e. 1 x 103/infected cell).
Electron microscopic analyses of the purified virions (Fig. 5 ) demonstrated the typical icosahedral morphology of empty poliovirus particles approximately 27 nm in diameter.
Immunological analyses of the poliovirus particles produced in S. frugiperda cells
Gradient-purified particles were used to raise antisera in mice and the ascitic fluids evaluated in terms of the presence of neutralizing antibodies. The reciprocal of the dilution giving 50~o neutralization was 180. Mouse ascitic fluid was also used in Western blot analyses with the purified particles recovered from recombinant baculovirus-infected cells (Fig. 4, lane 4) . The sera reacted strongly with the VP1 protein. The antibodies also recognized VP0 protein but exhibited only a faint reaction with VP3. the physical or antigenic properties of the expressed particles by comparison to mature or empty poliovirus particles (sedimentation coefficient, stability to pH, etc.).
Infectivity and other analyses with the expressed poliovirus particles
Expression of poliovirus proteins in S. frugiperda cells Mock-infected and recombinant baculovirus-infected S. frugiperda cells, 36 h post-infection,
were labelled with [asS]methionine and the products resolved by SDS-PAGE. Virions recovered from unlabetled AcLeon virus-infected cells by CsCI gradient centrifugation (Methods) were processed similarly. As shown in Fig. 6 (a) , Coomassie Brilliant Blue staining of the cell extracts did not clearly reveal the presence of poliovirus proteins, although for the purified particles (Fig.  6a, lane 4) , VP0, VP1 and VP3 were identified. However as demonstrated in Fig. 6(b) , Western blot analyses using a mixture of polyclonal rabbit sera, raised to poliovirus peptides and reactive to VP1, VP2 and VP3 (see Methods), indicated that the cells infected with the AcCAP21-T3 virus contained a protein with a high Mr (approx. 94K) (Fig. 6b, lane 2) that reacted with the antisera. The same antisera identified three major proteins in the cell extracts of the AcLeon virus-infected cells (Fig. 6b, lane 3) that were similar in size to the poliovirus VP0, VP1 and VP3 proteins. In the virion preparation (Fig. 6b, lane 4) other high Mr bands were also observed that reacted with the sera. However in subsequent experiments (see Fig. 4 ) they were not obtained when the virions were more rigorously purified. Autoradiography of the proteins (Fig. 6c) demonstrated that there was a labelled protein band corresponding to the 94K protein seen in the AcCAP21 virus-infected cell extracts subjected to Western blot analyses, although it was located in a region of the gel where there were other labelled bands in the mock-infected cell extracts. Against the background of A c N P V and S. frugiperda cell proteins the VP0, VP1 and VP3 proteins in the cell extracts from the AcLeon infection were not readily identified. When the flanking sequences to the A T G of the AcLeon and AcCAP21 viruses were reviewed it was observed that there was a T at the -3 position which, according to Kozak's models (Kozak, 1986) , might not represent the optimal arrangement for efficient translation initiation. In view of this, another series of recombinant viruses was prepared from a second capsid transfer vector designated pAcCAP69. In this vector the seven nucleotides that precede the poliovirus A T G codon were present with an A at the -3 position (see above). The vector was used to derive recombinant viruses containing the capsid region only (recombinants AcCAP69-1-1, AcCAP69-4-1). S. frugiperda cells were infected with these recombinant viruses and four independently obtained recombinants representing the AcCAP21 construction (AcCAP21-T3, -T4, -T5 and -T6) and the labelled, infected cell extracts were analysed as shown in Fig. 7 . Apart from the AcCAP21-T4 virus, the various AcCAP21 isolates appeared to synthesize similar levels of the 94K protein. The AcCAP21-T4 made less of this protein but contained another virus-induced protein that migrated in the 45K range (Fig. 7a, lane 5 arrowhead) . Western blot analyses demonstrated that only this band and the 94K band in the extract reacted with the poliovirus sera (data not shown). The origins and composition of the 45K band were not investigated further. When the AcCAP21 and AcCAP69 viruses were compared (Fig. 7b) , taking into account the different amounts of total radioactivity loaded on the different lanes, there did not appear to be a highly significant difference in the amount of the 94K protein made by the two AcCAP69 isolates by comparison to that made by the AcCAP21 viruses. Without an internally controlled study it could not be determined whether the AcCAP69 construction was any more favourable in terms of translation efficiency than the AcCAP21 virus. DISCUSSION Palmenberg (1982) has reported the in vitro synthesis and assembly of encephalomyocarditis virus shell-like structures (75S to 80S) using viral RNA and rabbit reticulocyte lysates. Similar data have been reported by Clarke & Sangar (1988) using SP6 RNA transcribed from a cDNA clone of foot-and-mouth disease virus and rabbit reticulocyte tysates. In this study, data have been presented which show that in insect cells a recombinant baculovirus containing the complete coding region of poliovirus (involving a 6.6 kbp insert) expresses non-infectious, but antigenic and immunogenic poliovirus particles. From Northern blot analyses the particles appear to be free from poliovirus RNA sequences. Although the level of synthesis is not high by comparison to the expression of other foreign genes by recombinant baculoviruses (Matsuura et al., 1987) . up to 180 ~tg of purified particles have been obtained per 2 x 109 infected S.frugiperda cells. The factors that might influence the level of poliovirus protein expression and variable recovery of purified virions (20 to 180 ~tg/2 z 109 infected cells) are under investigation. Structurally, the poliovirus virions that were produced resembled empty particles, containing VP0, VP1 and VP3 proteins, but no detectable VP2 or VP4. Analyses of the intracellular proteins made by recombinant baculoviruses containing only the capsid coding region of poliovirus (i.e. the P1 region) have demonstrated the synthesis of a 94K poliovirus protein product that is presumably the precursor to the capsid proteins. No evidence was obtained for the presence of VP0, VP1, VP2, VP3 or VP4 in these extracts, indicating that as predicted from other published reports, the poliovirus-coded proteases are required for capsid processing (Hanecak et al., 1982; Toyoda et al., 1986) .
It is not known whether active poliovirus polymerase is synthesized in the infected insect cells by the AcLeon recombinant baculovirus. Also no analyses have yet been undertaken to determine whether poliovirus negative strand synthesis accrues in the infected insect cells. These and other questions, such as the capability of custom-designed recombinant baculoviruses to express picornavirus particles with altered immunogenicity, are currently under investigation. The fact that the poliovirus particles synthesized were non-infectious and could be purified directly from infected cells offers opportunities to make a variety of novel genetic constructs which are not possible where picornavirus infectivity is required for isolation.
